|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase IV
|
|
|
|
Supportive care
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
A1501038 NCT00143312
|
|
|
|
|
|
|
|
Last Modified: 5/14/2007  First Published: 7/1/1997 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
12 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
EORTC-19961 PFIZER-150-307-000, NCT00003031
|
|
|
|
|
|
|
|
Last Modified: 9/1/1999  First Published: 5/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care
|
|
|
|
Completed
|
|
|
|
12 and over
|
|
|
|
NCI, Pharmaceutical / Industry
|
|
|
|
NCI-98-C-0063 PFIZER-150-603
|
|
|
|
|
|
|
|
Last Modified: 1/1/2001  First Published: 7/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care
|
|
|
|
Completed
|
|
|
|
12 and over
|
|
|
|
NCI
|
|
|
|
NCI-99-C-0094B NCI-99-C-0094
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Completed
|
|
|
|
2 to 12
|
|
|
|
NCI, NHLBI
|
|
|
|
416 BMTCTN-0101, UF-G-074-2003, FHCRC-1808.00, CDR0000349374, U01 HL069294, NCT00075803
|
|
|
|
|
|
|
|
Last Modified: 12/19/2004  First Published: 4/23/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Supportive care
|
|
|
|
Completed
|
|
|
|
2 and over
|
|
|
|
NCI
|
|
|
|
NCI-03-C-0111 NCT00059878
|
|
|
|
|
|
|
|
Last Modified: 4/1/2005  First Published: 7/26/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Supportive care
|
|
|
|
Completed
|
|
|
|
2 to 11
|
|
|
|
NCI
|
|
|
|
NCI-03-C-0218 NCT00066599
|
|
|
|
|
|
|
|
Last Modified: 10/1/1998  First Published: 11/1/1997 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
MCV-CCHR-9603-2H PFIZER-95CK39-0673, NCI-G97-1325
|
|
|
|
|
|
|
|
Last Modified: 3/1/2001  First Published: 8/1/2000 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Supportive care
|
|
|
|
Completed
|
|
|
|
2 to 12
|
|
|
|
NCI
|
|
|
|
NCI-00-C-0150
|
|
|
|
|
|
|
|
Last Modified: 7/12/2007  First Published: 2/20/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
12 and over
|
|
|
|
NCI
|
|
|
|
UCLA-0307071 NCT00079222
|
|
|
|